2016 the list of the world's most brand value pharmaceutical companies


Release time:

2016-04-08


Recently, Interbrand Health, a subsidiary of Interbrand, the world's largest brand management consulting firm, released "The Most Brand Value Pharmaceutical Company in 2016".
Yao Chenggang, general manager of Interbrand China, said in his 2016 Spring Festival message that in the complicated brand world, how to define its brand vision, core competitiveness and how to construct these differences in the future is an issue that global brand owners are paying more and more attention.
It is reported that the list uses a Interbrand of ISO-certified brand value assessment methods to measure the contribution of corporate brands to business performance. The report gathers feedback from health care providers, health care payers, and government policy makers through a global online survey, which is based on the views of 1900 health care professionals from around the world.
InterbrandHealth CEO Jane Parker believes that brand power can help companies judge their strengths and weaknesses by comparing brand performance, thus driving tangible business growth with brand equity. Under the trend of increasingly fierce competition in the pharmaceutical industry, it is particularly important for the major pharmaceutical giants to release this list InterbrandHealth. Nowadays, medical services have changed to "patient-centered", and for patients who are one of the consumers, the brand of drugs is very important.
Jane Parker said that the following 10 companies are embracing the changes in the healthcare industry. They have effectively improved the company's brand value, maintained the company's business growth, increased innovation, and provided realistic solutions for patients around the world.
Attached: Pharmaceutical Enterprises with the Most Brand Value in 2016
1, Pfizer
Pfizer, headquartered in New York, ranks first among the world's most valuable pharmaceutical companies with $19.985 billion, and is one of the world's largest pharmaceutical brands.
Pfizer's corporate brand has more influence on healthcare decisions than the pharmaceutical industry average, and its expertise extends to multiple therapeutic areas, such as immune and inflammatory diseases, cardiovascular and metabolic diseases, oncology, vaccines, neuroscience and pain, rare diseases, and more. Healthcare professionals believe that this expertise, along with its broad therapeutic field, allows Pfizer to provide solutions to diseases that exceed their expectations. Pfizer's legacy of globality and reliability has earned the company an impressive overall brand strength score, outpacing its peers.
In November 2015, Pfizer Allergan reached a merger agreement. The impact of the acquisition project on Pfizer's brand value is also very noteworthy.
2, Roche
Roche was founded in 1896 and is headquartered in Basel, Switzerland. In 2009, Roche acquired the biotechnology company Genentech and became the world's largest biotechnology brand. At the same time, Roche is also the world's largest supplier of in vitro diagnostic reagents. Its focus areas include oncology, neuroscience, infectious diseases, Immunology and ophthalmology. Roche ranks second among the world's most valuable pharmaceutical companies with a brand value of US $15.479 billion.
Healthcare professionals believe that Roche is very focused on the development of new drugs, and its drugs and diagnostic reagents are far ahead in personalized treatment. In addition, Roche is committed to improving the quality of life of patients, and the relationship with the government, relevant departments and relevant management personnel is also very harmonious.
3. Mercadon
Merck's business covers more than 140 countries around the world, ranking third among the world's most valuable pharmaceutical companies with $13.88 billion billion.
Healthcare professionals believe that Merck's corporate brand is in line with the development of its pharmaceutical services and has developed a large number of experts and talents for the pharmaceutical industry.
Merck focuses on a number of therapeutic areas, including diabetes, cardiovascular disease, infectious diseases, Alzheimer's disease and cancer, as well as animal health.
2016 marks the 125 anniversary of Merck's founding. The company will strive to improve the quality of life of patients, enhance the company's reputation, and strengthen research on new drugs.
4. Janssen
Johnson & Johnson's Janssen Pharmaceuticals ranks fourth among the world's most brand-valued pharmaceutical companies with $13.866 billion billion. The company's products mainly have five therapeutic areas: cardiovascular and metabolic, immune, infectious diseases and vaccines, nerves, and tumors.
Janssen's corporate brand value allows healthcare professionals to evaluate above the industry average, which is inseparable from its status as a subsidiary of Johnson & Johnson.
Janssen's value proposition is to "improve the lives of patients and change the way disease is managed and prevented". Healthcare professionals believe that Janssen is committed to "patient-centered" and provides excellent healthcare solutions for the medical industry. At the same time, we focus on establishing a strong and harmonious relationship with patients and increasing scientific and new drug research.
5, Novartis
Novartis, headquartered in Basel, Switzerland, ranked fifth 2016 the world's most valuable pharmaceutical company with a brand value of $13.496 billion. The company is involved in several therapeutic areas, including cardiovascular and metabolic, eye care, immunology and dermatology, neuroscience, oncology and others. Novartis has strengthened its oncology product portfolio over the past 12 months through the acquisition of GSK Oncology and R & D products.
Novartis's corporate brand has more influence on healthcare professions' medication decisions than the industry average. Novartis aims to provide solutions to the changing needs of patients worldwide. Healthcare professionals believe that Novartis's innovative approach to comprehensive health solutions is leading the industry. However, respondents to this survey believe that a large part of Novartis's brand value comes from clinical treatment, including the application of information technology and innovative partnerships with non-traditional pharmaceutical businesses such as Google.
6. Amjin
Founded in 1980, Amjin is the world's first biotechnology company, headquartered in Thousand Oaks, California, USA. This time the company ranked 6th among the world's most valuable pharmaceutical companies in 2016 with US $13.461 billion.
The company focuses on oncology/hematology to meet the medical needs of high, bone health, kidney, nervous system, inflammation and cardiovascular disease treatment areas.
The company's brand is second only to Pfizer overall in its influence on the medication decisions of healthcare professionals, and respondents to this survey also agree with Amgo's innovation, research and solving clinical needs in Junior College fields.
Amjin has actively cooperated with pharmaceutical giants such as Merck, Roche and Novartis. In addition, the market value of anemia drugs continues to increase. As a result, healthcare professionals have a strong preference for Amjin.
7, Gilead Science
Gilead Science was founded in 1987 and is the youngest biopharmaceutical company on the list. It ranks 7th among the world's most valuable pharmaceutical companies in 2016 with US $13.361 billion.
Gilead Sciences is committed to providing faster and better treatment options for patients. Its main therapeutic areas include HIV / AIDS, hepatitis B and C, hematology, oncology, cardiovascular disease, inflammation, and respiratory diseases.
Healthcare professionals recognize Gilead Science's increased R & D investments to address healthcare needs. The company's brand has grown significantly after acquiring Pharmasset and launching a revolutionary new hepatitis C drug Solvadi. In addition, the company continues to innovate in the field of HIV treatment, where it has traditional advantages, and provides patients with valuable services and programs.
8. Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a leading company in the field of diabetes treatment, with a history of more than 90 years, ranking the 8th most valuable pharmaceutical company in the world 2016 $10.206 billion million. In addition to diabetes, Novo Nordisk also has significant performance in areas such as hemophilia, growth hormone therapy and hormone replacement therapy.
Novo Nordisk's brand values reflect its company's mission to prevent, treat and cure diabetes, improve the quality of life for people with diabetes, and its position in the diabetes industry, which has a much higher impact on healthcare professions' medication decisions than the industry average.
Healthcare professionals highly recognize Novo Nordisk's dedication to improving the quality of life of people with chronic diseases and to delivering healthcare solutions that exceed expectations.
9. AstraZeneca
Headquartered in London, UK, AstraZeneca is an innovative biopharmaceutical company dedicated to the development and commercial promotion of innovative drugs in cardiovascular, metabolic, respiratory, inflammatory, autoimmune, oncology, infection, neurological diseases and other fields. Its business covers more than 100 countries around the world, and its innovative drugs are used by millions of patients around the world. This time, it ranked 9th among the world's most brand-valued pharmaceutical companies in 2016 with US $8.123 billion.
AstraZeneca's corporate goal is to advance science, discover life-changing drugs, and create a brand positioning of "what science can do. Healthcare professionals believe that AstraZeneca has a strong market share, is a leader in the pharmaceutical industry, has strong research and development capabilities, and is extremely focused on improving patient outcomes.
In 2014, AstraZeneca rejected Pfizer's acquisition, while reiterating that the company was growing well and strengthening its cardiovascular, metabolic and respiratory diseases businesses through a series of smart acquisitions.
10, GlaxoSmithKline
GlaxoSmithKline was formed in December 2000 by the merger of GlaxoWellcome and SmithKline. Headquartered in London, UK, it is the world leader in the three major businesses of pharmaceuticals, vaccines and consumer health care, and ranks the 10th most valuable pharmaceutical company in the world in 2016 with US $6.778 billion billion.
GlaxoSmithKline focuses on a series of acute and chronic diseases in the fields of respiratory diseases, AIDS, cardiovascular diseases, metabolic diseases and urinary diseases, and has a number of blockbuster drugs in the fields of respiratory diseases and HIV infection.
Healthcare professionals believe that GlaxoSmithKline is a leader in many disease areas, and its advantage lies in using its technology and expertise to solve the needs of HCPs and patients. GlaxoSmithKline acquired Novartis's global vaccines business (excluding flu vaccines) in 2014 and swapped it with the cancer drugs business.